Porcine acute liver failure model established by two-phase surgery and treated with hollow fiber bioartificial liver support system

被引:0
|
作者
Yi Gao
机构
关键词
Acute liver failure; Animal model; Bioartificial liver; Micro-capsulized activated carbon adsorbing; Porcine hepatocyte;
D O I
暂无
中图分类号
R575.3 [肝功能衰竭];
学科分类号
1002 ; 100201 ;
摘要
AIM: To establish a highly reproducible animal model of acute liver failure (ALF), for assessing the effect of bioartificial liver support system (BALSS). METHODS: A two-phase complete liver devascularization procedure was performed in eight loco-hybrid pigs. Blood biochemical index and liver biopsy were studied every 2 h after surgery, and survival time was recorded. The BALSS constructed with high volume recirculating technique was a hollow fiber circulating system consisting of a hepatocyte reactor-hollow fiber module inoculated with microcarrieradhering hepatocytes, and a double pump, heparinized, thermostabilized, micro-capsulized activated carbonadsorbing plasmapheresis system. Twelve pigs undergoing two-phase surgery were randomized into: control group (perfused without hepatocytes, n=6) and treatment group (perfused with hepatocytes, n=6). Intergroup liver biochemical indexes, survival time, and liver pathological changes were analyzed at regular intervals. RESULTS: Two-phase surgery was performed in all the experimental pigs, and there was no obvious difference between their biochemical indexes. After 3 h of phase II surgery, ammonia (Amm) increased to (269±37) |umol/L. After 5 h of the surgery, fibrinogen (Fib) decreased to (1.5±0.2) g/L. After 7 h of the surgery, ALT, AST, Tbil and PT were (7.6±1.8) nka/L, (40±5) nka/L, (55±8) nmol/L and (17.5±1.7) nka/L respectively. After 9 h of surgery, ALB and Cr were (27±4) g/L and (87±9) nmol/L. After 13 h of surgery, BUN was (3.5±0.9) μmol/L. All the above values were different from those determined before surgery. Survival time of pigs averaged 13.5±1.4 h. ALF pigs in the other group were treated with BALSS. The comparison analysis between the treated and control animals showed the changes of Tbil, PT, Alb, BUN, Cr, Fib, and Amm (P<0.01), but there was no change of ALT and AST. The survival time was statistically different (P<0.01), and there was no significant difference in histological changes. CONCLUSION: The porcine ALF model established by two-phase devascularized surgery is valid and reproducible. The hollow fiber BALSS can meet the needs of life support and is effective in treating ALF.
引用
收藏
页码:5468 / 5474
页数:7
相关论文
共 50 条
  • [1] Porcine acute liver failure model established by two-phase surgery and treated with hollow fiber bioartificial liver support system
    Gao, Yi
    Mu, Ning
    Xu, Xiao-Ping
    Wang, Yan
    WORLD JOURNAL OF GASTROENTEROLOGY, 2005, 11 (35) : 5468 - 5474
  • [2] Bioartificial liver support system using porcine hepatocytes entrapped in a three-dimensional hollow fiber module with collagen gel: An evaluation in the swine acute liver failure model
    Naka, S
    Takeshita, K
    Yamamoto, T
    Tani, T
    Kodama, M
    ARTIFICIAL ORGANS, 1999, 23 (09) : 822 - 828
  • [3] Functional Evaluation of a Bioartificial Liver Support System Using Immobilized Hepatocyte Spheroids in a Porcine Model of Acute Liver Failure
    Lee, Ji-Hyun
    Lee, Doo-Hoon
    Lee, Sanghoon
    Kwon, Choon Hyuck David
    Ryu, Jae-Nam
    Noh, Jeong-Kwon
    Jang, In Keun
    Park, Hey-Jung
    Yoon, Hee-Hoon
    Park, Jung-Keug
    Kim, Young-Jin
    Kim, Sung-Koo
    Lee, Suk-Koo
    SCIENTIFIC REPORTS, 2017, 7
  • [4] Functional Evaluation of a Bioartificial Liver Support System Using Immobilized Hepatocyte Spheroids in a Porcine Model of Acute Liver Failure
    Ji-Hyun Lee
    Doo-Hoon Lee
    Sanghoon Lee
    Choon Hyuck David Kwon
    Jae-Nam Ryu
    Jeong-Kwon Noh
    In Keun Jang
    Hey-Jung Park
    Hee-Hoon Yoon
    Jung-Keug Park
    Young-Jin Kim
    Sung-Koo Kim
    Suk-Koo Lee
    Scientific Reports, 7
  • [5] Support of acute liver failure patients with a bioartificial liver
    Watanabe, FD
    Demetriou, AA
    JOURNAL OF CLINICAL APHERESIS, 1996, 11 (03) : 138 - 142
  • [6] Assessment of bioartificial liver support in acute liver failure
    Hughes, RD
    Williams, R
    INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS, 1996, 19 (01): : 3 - 6
  • [7] Experimental research on porcine hepatocyte based bioartificial liver support system to treat canines with acute liver failure
    Chen, XP
    Xue, YL
    Li, XJ
    Zhang, ZY
    Li, YL
    Huang, ZQ
    PROCEEDINGS OF THE 2003 SYMPOSIUM OF CHINA POSTDOCTORS AND ACADEMICIANS ON LIFE SCIENCE, 2003, : 321 - 325
  • [8] No transmission of porcine endogenous retrovirus in an acute liver failure model treated by a novel hybrid bioartificial liver containing porcine hepatocytes
    Han, Bing
    Shi, Xiao-Lei
    Zhang, Yue
    Gu, Zhong-Ze
    Yuan, Xian-Wen
    Ren, Hao-Zhen
    Qiu, Yong
    Ding, Yi-Tao
    HEPATOBILIARY & PANCREATIC DISEASES INTERNATIONAL, 2015, 14 (05) : 492 - 501
  • [9] No transmission of porcine endogenous retrovirus in an acute liver failure model treated by a novel hybrid bioartificial liver containing porcine hepatocytes
    Bing Han
    Xiao-Lei Shi
    Yue Zhang
    Zhong-Ze Gu
    Xian-Wen Yuan
    Hao-Zhen Ren
    Yong Qiu
    Yi-Tao Ding
    Hepatobiliary & Pancreatic Diseases International, 2015, 14 (05) : 492 - 501
  • [10] Preclinical trial of a bioartificial liver support system in a porcine fulminant hepatic failure model
    Sheil, AGR
    Sun, J
    Mears, DC
    Waring, M
    Woodman, K
    Johnston, B
    Horvat, M
    Watson, KJ
    Koutalistras, N
    Wang, LS
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF SURGERY, 1996, 66 (08): : 547 - 552